| Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response G Chen, AC Huang, W Zhang, G Zhang, M Wu, W Xu, Z Yu, J Yang, ... Nature 560 (7718), 382-386, 2018 | 2095 | 2018 |
| Precision medicine for hepatocellular carcinoma: driver mutations and targeted therapy XX Ding, QG Zhu, SM Zhang, L Guan, T Li, L Zhang, SY Wang, WL Ren, ... Oncotarget 8 (33), 55715, 2017 | 104 | 2017 |
| c-Rel is a myeloid checkpoint for cancer immunotherapy T Li, X Li, A Zamani, W Wang, CN Lee, M Li, G Luo, E Eiler, H Sun, ... Nature cancer 1 (5), 507-517, 2020 | 69 | 2020 |
| Hepatitis B virus X protein stabilizes amplified in breast cancer 1 protein and cooperates with it to promote human hepatocellular carcinoma cell invasiveness Y Liu, Z Tong, T Li, Q Chen, L Zhuo, W Li, RC Wu, C Yu Hepatology 56 (3), 1015-1024, 2012 | 56 | 2012 |
| Stiff matrix induces exosome secretion to promote tumour growth B Wu, DA Liu, L Guan, PK Myint, LK Chin, H Dang, Y Xu, J Ren, T Li, Z Yu, ... Nature cell biology 25 (3), 415-424, 2023 | 52 | 2023 |
| Prognostic value of EGFR and KRAS in resected non-small cell lung cancer: a systematic review and meta-analysis SM Zhang, QG Zhu, XX Ding, S Lin, J Zhao, L Guan, T Li, B He, HQ Zhang Cancer Management and Research, 3393-3404, 2018 | 39 | 2018 |
| HRS phosphorylation drives immunosuppressive exosome secretion and restricts CD8+ T-cell infiltration into tumors L Guan, B Wu, T Li, LA Beer, G Sharma, M Li, CN Lee, S Liu, C Yang, ... Nature communications 13 (1), 4078, 2022 | 32 | 2022 |
| Genome-wide analysis reveals TNFAIP8L2 as an immune checkpoint regulator of inflammation and metabolism T Li, W Wang, S Gong, H Sun, H Zhang, AG Yang, YH Chen, X Li Molecular immunology 99, 154-162, 2018 | 29 | 2018 |
| MEIS2C and MEIS2D promote tumor progression via Wnt/β-catenin and hippo/YAP signaling in hepatocellular carcinoma L Guan, T Li, N Ai, W Wang, B He, Y Bai, Z Yu, M Li, S Dong, Q Zhu, ... Journal of Experimental & Clinical Cancer Research 38, 1-14, 2019 | 21 | 2019 |
| Myeloid-derived suppressor cell differentiation in cancer: Transcriptional regulators and enhanceosome-mediated mechanisms N Fultang, X Li, T Li, YH Chen Frontiers in immunology 11, 619253, 2021 | 17 | 2021 |
| Identifying key regulating miRNAs in hepatocellular carcinomas by an omics’ method B He, P Lu, L Guan, T Li, L Zhang, QG Zhu, XX Ding, SM Zhang, XM Chen, ... Oncotarget 8 (61), 103919, 2017 | 10 | 2017 |
| The TIPE molecular pilot that directs lymphocyte migration in health and inflammation H Sun, M Lin, A Zamani, JR Goldsmith, AE Boggs, M Li, CN Lee, X Chen, ... Scientific Reports 10 (1), 6617, 2020 | 8 | 2020 |
| The c-Rel-c-Myc axis controls metabolism and proliferation of human T leukemia cells X Li, G Luo, T Li, H Sun, W Wang, E Eiler, JR Goldsmith, YH Chen Molecular immunology 125, 115-122, 2020 | 7 | 2020 |
| Decoupling tumor cell metastasis from growth by cellular pilot protein TNFAIP8 M Li, X Li, JR Goldsmith, S Shi, L Zhang, A Zamani, L Wan, H Sun, T Li, ... Oncogene 40 (46), 6456-6468, 2021 | 3 | 2021 |
| Downregulation of TMEM220 Promotes Tumor Progression in Hepatocellular Carcinoma T Li, L Guan, G Tang, B He, L Huang, J Wang, M Li, Y Bai, X Li, H Zhang Cancer Gene Therapy, 2021 | | 2021 |
